• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Covid origin studies say evidence points to Wuhan market

Mary Wilson

Well-known member
4 hours ago

By Victoria Gill
Science correspondent, BBC News

Scientists say there is "compelling evidence" that Wuhan's Huanan seafood and wildlife market was at the centre of the Covid-19 outbreak.

Two peer-reviewed studies published on Tuesday re-examine information from the initial outbreak in the Chinese city.

One of the studies shows that the earliest known cases were clustered around that market.

The other uses genetic information to track the timing of the outbreak.

It suggests there were two variants introduced into humans in November or early December 2019.

Together, the researchers say this evidence paints a picture that Sars-Cov-2 was present in live mammals that were sold at Huanan market in late 2019. They say it was transmitted into people who were working or shopping there in two separate "spillover events", where a human contracted the virus from an animal.

One of the researchers involved, virologist Prof David Robertson from the University of Glasgow, told BBC News that he hoped the studies would "correct the false record that the virus came from a lab".

Pandemic epicentre

Two years of scientific effort to understand the virus that causes Covid-19 have provided these researchers with a more informed perspective.

This has enabled them to address a key conundrum in the earliest patient data: That out of hundreds of people who were hospitalised with Covid-19 in Wuhan, only about 50 had a direct, traceable link to the market.

"That was really puzzling that most cases could not be linked to the market," said Prof Robertson. "But knowing what we know about the virus now, it's exactly what we would expect - because many people only get very mildly ill, so they would be out in the community transmitting the virus to others and the severe cases would be hard to link to each other."

This Covid-19 case-mapping research found that a large percentage of early patients - with no known connection to the market, meaning they neither worked nor shopped there - did turn out to live near it.

This supports the idea that the market was the epicentre of the epidemic, said Prof Michael Worobey, lead author and biologist from the University of Arizona, with sellers getting infected first and setting off a "chain of infections among community members in the surrounding area".

"In a city covering more than 3,000 sq miles (7,770 sq km), the area with the highest probability of containing the home of someone who had one of the earliest Covid-19 cases in the world was an area of a few city blocks, with the Huanan market smack dab inside it," said Prof Worobey.

The lab leak theory

... One of the subjects of a fierce international blame game - primarily between politicians in the US and China - was a theory that the virus could have been leaked from a Wuhan laboratory, the Wuhan Institute of Virology.

But that hypothesis, said Prof Stuart Neil from Kings College, "can't explain the data".

"We're now as sure as we can be, based on the fragmentary evidence we do have, that this was a spillover event that happened in the market."

Crowded, live animal markets, many scientists agree, provide an ideal transmission hotspot for new diseases to "spill over" from animals. And in the 18 months up to the beginning of the pandemic, a separate study showed that nearly 50,000 animals - of 38 different species - were sold at markets in Wuhan.

Prof Neil said the pandemic was very likely to have been a consequence of an "unhealthy, cruel and unhygienic practice that Chinese authorities had been warned about". ...

https://www.bbc.com/news/science-environment-62307383
 
They don't have the WIV marked on the map, but see drawing D in the link below from the Science paper and then look at this map. The lab would be the center of a case circle, too, if not for the lake.

https://www.science.org/cms/10.1126...fe/assets/images/large/science.abp8715-f1.jpg


This paper makes a case for the market being a superspreader event, (such as the Canary Island festivities in the monkeypox outbreak). The case is stronger that was the case, rather than the market being the origin.

https://www.sciencedirect.com/science/article/pii/S0013935122010295?via=ihub
Virginie Courtier-Orgogozo, Francisco A. de Ribera,
SARS-CoV-2 infection at the Huanan seafood market,
Environmental Research, Volume 214, Part 1, 2022, 113702, ISSN 0013-9351,
https://doi.org/10.1016/j.envres.2022.113702.
Even if several early market outbreak cases may turn out to be explained by human-to-human transmission, we note that it remains unclear how the first person at the Huanan market was contaminated and whether the market was a site of animal-to-human contamination. However, taking into account the exact location of the early patients in the market can help to refine scenarios about the origin of the pandemic. The earliest detected case is located in a stall that is a few dozens of meters north compared to the presumed animal source hotspot highlighted in the recent Worobey et al. preprint (Worobey et al., 2022). If this patient was infected at the market by an animal, then either the place highlighted by Worobey et al. for animal-to-human contamination is incorrect and should be close to this first patient or this early case somehow contracted the virus around the distant stall highlighted by Worobey et al. Alternatively, this earliest case at the market was infected by humans and the initial introduction of the virus into the human population occurred earlier.

If a cluster of patients located a few meters away from each other had been detected at the market in the early days of the pandemic, it would be natural to suggest an animal source hotspot and animal-to-human contamination at the market. However, the first detected patients are relatively far from each other. We suggest here that they infected each other in common rooms such as toilets. Our analysis therefore decreases the possibility of substantial animal-to-human contamination at the market.
 
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 - AAAS

https://flutrackers.com/forum/forum...-multiple-zoonotic-origins-of-sars-cov-2-aaas

The cornerstone research relied on by this paper has been questioned and the lead author of that paper who was the China CDC chief has suddenly left his position.

This geographic proximity is consistent with a separate and subsequent origin of lineage A at the Huanan market in late-November 2019. The presence of lineage A virus at the Huanan market was confirmed by Gao et al. (43) from a sample taken from discarded gloves.

Note Quay had a professor of statistic at UCLA verify his work in the video below.
https://www.youtube.com/watch?v=6gEhXiuy2sA

Steven Quay, MD, PhD

The Huanan Market Origin of SARS-CoV-2 is Unlikely: The ancestral lineage-containing specimen appears to have arisen from post-collection laboratory contamination. -- Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions. He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented. His current passion is the prevention of the two million yearly breast cancer cases worldwide.
 
Back
Top Bottom